Actively Recruiting

Phase Not Applicable
Age: 20Years - 39Years
FEMALE
ID06481969

Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency

Led by Rui Yang · Updated on 2024-11-14

260

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating the use of autologous adipose stromal vascular fraction (SVF) to improve pregnancy outcomes in women with premature ovarian insufficiency (POI). This single-center, prospective, randomized controlled trial aims to evaluate the safety and effectiveness of SVF treatment compared to conventional reproductive care in infertile patients with POI. The study will enroll 260 women diagnosed with POI and is sponsored by Rui Yang. Participants will be randomly assigned to one of two groups. The experimental group will undergo lower abdominal liposuction to collect fat tissue, from which SVF will be prepared and then injected into both ovaries under ultrasound guidance. The control group will receive standard assisted reproductive treatments without SVF. Both groups will receive conventional in vitro fertilization (IVF) procedures and related reproductive care. Treatment and follow-up will span approximately two years, including six visits and three phone follow-ups. During the study, researchers will monitor various outcomes such as the cumulative clinical pregnancy rate within six months, hormone levels, follicle counts, ovarian volume, menstrual status, pregnancy outcomes, and offspring health over two years. Safety will also be assessed by tracking any adverse reactions. Participants will undergo tests, hormone measurements, ultrasounds, and questionnaires to evaluate these outcomes and monitor their health throughout the study period.

CONDITIONS

Brief Title

Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency

Who Can Participate

Age: 20Years - 39Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women aged 20 to 39 years with childbearing requirements
  • Cessation of menstruation or irregular periods for at least 4 months
  • Elevated basal follicle stimulating hormone (FSH) levels above 25 U/L on two separate tests
  • Serum Anti-Mullerian hormone (AMH) level of 1.1 ng/ml or lower
  • Intact uterus and both ovaries
  • Voluntary participation with informed consent obtained
Not Eligible

You will not qualify if you...

  • Autoimmune diseases
  • Abnormal or uncontrolled thyroid function
  • Tumors in both ovaries that are not clearly benign or malignant
  • History of malignant tumors, radiation therapy, or chemotherapy
  • History of venous thrombosis or pulmonary embolism
  • Severe illnesses unsuitable for pregnancy affecting major body systems
  • Recent or ongoing use of systemic glucocorticoids or immunosuppressants
  • Allergy to active ingredients or excipients of study drugs
  • Family history of severe genetic diseases or gynecologic cancers

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Approximately 6 months

Participants receive either autologous adipose stromal vascular fraction (SVF) treatment involving lower abdominal liposuction, SVF preparation, and ovarian injection, or conventional IVF treatment according to clinical routine.

6 visits and 3 follow-up phone calls over 2 years

Follow-up

Duration - Up to 2 years after treatment

Participants are monitored for pregnancy outcomes, health status of offspring, and any adverse reactions up to 2 years after treatment.

3 follow-up phone calls

Trial Site Locations

Total: 1 location

1

Peking University Third Hospital

Beijing, Beijing Municipality, China, 100191

Actively Recruiting

Loading map...

Research Team

R

Rui Yang, M.D.

Y

Yaodong Zhang, Bachelor

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Multicenter Observational Study on the Development and Hea...

Premature Ovarian Insufficiency

Actively Recruiting

2 locations

Application of Platelet-rich Plasma (PRP) in Reproductive Me...

Premature Ovarian Insufficiency

Actively Recruiting

1 location

Clinical Application of Serum Anti-Müllerian Hormone (AMH) M...

Anti-Müllerian Hormone

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Efficacy and safety of autologous adipose tissue-derived stromal vascular fraction in patients with premature ovarian insufficiency: protocol for a single-centre randomised controlled trial.

Yaodong Zhang, Hui Liu, Yanru Lou...

https://pubmed.ncbi.nlm.nih.gov/40180397